|drug984||mouthrinse without bêta-cyclodextrin and citrox Wiki||1.00|
|D045169||Severe Acute Respiratory Syndrome NIH||0.07|
|D018352||Coronavirus Infections NIH||0.06|
There is one clinical trial.
Given the current lack of effective COVID-19 treatment, it is necessary to explore alternative methods to contain the spread of the infection, focusing in particular on its mode of transmission. The modes of person-to-person transmission of SARS-CoV-2 are direct transmission, such as sneezing, coughing, transmission through inhalation of small droplets, and transmission through contact, such as contact with nasal, oral and eye mucous membranes. SARS-CoV-2 can also be transmitted directly or indirectly through saliva. The use of antiviral mouthrinses may be used as adjunctive therapy.
Description: Quantitative PCR experiments will be performed and a quantitative analysis of the salivary samples will be madeMeasure: Change from Baseline amount of SARS-CoV-2 in salivary samples at 7 days Time: 7 days
Description: Quantitative PCR experiments will be performed and a quantitative analysis of the nasal samples will be madeMeasure: Change from Baseline amount of SARS-CoV-2 virus in nasal samples at 7 days Time: 7 days